Lupin Ltd. Sees Significant Open Interest Surge Signalling Bullish Market Positioning

Open Interest and Volume Dynamics

On 24 June 2026, Lupin Ltd. recorded an open interest of 30,647 contracts in its derivatives, marking a substantial increase of 4,096 contracts or 15.43% compared to the previous OI of 26,551. This rise in open interest is accompanied by a trading volume of 34,940 contracts, indicating robust participation in the futures and options market. The futures value stood at ₹92,840.64 lakhs, while the options segment exhibited an impressive notional value of approximately ₹26,518.29 crores, culminating in a total derivatives value of ₹95,566.36 lakhs.

The underlying stock price closed at ₹2,374, just 4.94% shy of its 52-week high of ₹2,494, underscoring the stock’s strong price momentum. Lupin’s price has outperformed its sector by 0.61% on the day, with a 1.56% gain over the past two consecutive trading sessions. The stock is trading above all key moving averages – 5-day, 20-day, 50-day, 100-day, and 200-day – reinforcing the positive technical outlook.

Market Positioning and Investor Participation

The surge in open interest alongside rising volumes suggests that market participants are actively positioning themselves for potential price movements. The delivery volume on 23 June was 4.34 lakh shares, a 2.4% increase over the five-day average delivery volume, indicating growing investor conviction in the stock’s prospects. Additionally, the stock’s liquidity remains healthy, with the average traded value supporting trade sizes up to ₹4.16 crores, facilitating smooth execution for institutional and retail investors.

Such a combination of rising open interest, volume, and delivery participation typically points to fresh capital inflows and a strengthening trend. Traders appear to be taking directional bets, possibly anticipating further upside given Lupin’s strong fundamentals and sectoral tailwinds.

Mojo Score and Rating Update

Lupin Ltd. currently holds a Mojo Score of 77.0, reflecting a strong buy rating, albeit a slight downgrade from its previous “Strong Buy” grade as of 25 May 2026. This adjustment suggests a cautious but optimistic stance by analysts, factoring in recent price action and sector dynamics. The company’s mid-cap market capitalisation of ₹1,08,688.75 crores places it well within the ambit of active institutional interest, further supported by its consistent outperformance relative to the Pharmaceuticals & Biotechnology sector.

Technical and Fundamental Outlook

The stock’s position above all major moving averages signals sustained upward momentum, which is often a precursor to further gains. The proximity to its 52-week high indicates that Lupin is nearing a critical resistance level, where investor sentiment and derivative positioning will play a pivotal role in determining the next directional move.

Fundamentally, Lupin’s robust market cap and sector leadership underpin its appeal. The increased open interest in derivatives may reflect hedging activity by institutional investors or speculative bets on continued price appreciation. The sizeable futures and options notional values highlight the stock’s prominence in the derivatives market, attracting diverse market participants.

Potential Directional Bets and Market Implications

The 15.43% jump in open interest, coupled with rising volumes, suggests that traders are building fresh positions rather than merely closing existing ones. This behaviour typically indicates confidence in a directional move, most likely bullish given the stock’s recent gains and technical strength. However, investors should remain vigilant for any sudden reversals near the 52-week high, which could trigger profit booking or increased volatility.

Options market activity, with its substantial notional value, may also be signalling strategic positioning through calls and puts. The balance between call and put open interest, though not detailed here, would provide further clarity on market sentiment. Nevertheless, the overall data points to a positive bias in the near term.

Conclusion: A Bullish Signal with Cautious Optimism

The recent surge in Lupin Ltd.’s open interest and trading volumes in the derivatives market, combined with its strong price performance and technical indicators, points to a bullish market stance. Investors and traders appear to be positioning for further upside, supported by solid fundamentals and sectoral tailwinds. While the downgrade from “Strong Buy” to “Buy” suggests some caution, the overall outlook remains positive.

Market participants should monitor Lupin’s price action closely, especially as it approaches its 52-week high, to gauge whether the momentum sustains or faces resistance. The derivatives data provides valuable insight into market sentiment and potential directional bets, making Lupin a stock to watch in the Pharmaceuticals & Biotechnology space.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →